urologist-icon
Kidney biopsy report
Dear Doctor My father recently underwent kidney biopsy and the report says that Features are of Mesangioproliferative glomerulonephritis, morphologically favouring IgA Nephropathy (HAAS Class IV; Oxford classification M1E0SOTO -CO). Please see the report and my father is worried about that and they are given a tablet and said to come back after 15 days and I have enclosed report also
50 Views v

Answers (2)

20000+ health queries resolved in last month
Care AI Shimmer
Hi The biopsy report is indicative of IgA Nephropathy needs to be confirmed with IF. Secondly biopsy features seem benign (good prognosis). But need more details to comment on prognosis.
Next Steps
Regular follow up with Nephrologist
Answered
Flag this Answer
Flag this answer
Let others know if this answer was helpful
Was this answer helpful?

Didn't find the answer you are looking for?

Talk to experienced doctor online and get your health questions answered in just 5 minutes.

doctor profile image doctor profile image doctor profile image doctor profile image +147
Consult with a doctor
Online now
Need to know his current creatinine level and urine protein report
Answered
Flag this Answer
Flag this answer
Let others know if this answer was helpful
Was this answer helpful?
Disclaimer : The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding your medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Disclaimer : The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding your medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.